The J.P. Morgan biopharma and medtech reports are here for 2024 covering therapeutics and medtech licensing and funding to explore the movement in each sector, offering insight into industry and investment trends that defined the fourth quarter of 2024 and will shape the start of 2025. The reports, powered by DealForma, are available here.
